SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Progenitor (PGEN)
PGEN 4.140+2.2%Oct 31 9:30 AM EDT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Lokness who wrote (29)2/24/1998 1:07:00 PM
From: Czechsinthemail   of 106
 
Steve,

According to PGEN's annual report, the Mercator acquisition was based on their perceived need to develop a larger organization to compete more effectively in genomics:

"Mercator Genetics, Inc., a California genomics company that had recently discovered the genetic basis for an iron overload disease affecting over a million Americans. Mercator had a strong scientific organization with close ties to the Stanford Human Genome Center. Where one company had needs the other had strengths."

Baird
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News